Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology
SUMMARY Subarachnoid haemorrhage (SAH) is a major contributor to the burden of stroke on society. Treatment options are limited and animal models of SAH do not always mimic key pathophysiological hallmarks of the disease, thus hindering development of new therapeutics. Inflammation is strongly assoc...
Saved in:
Main Authors: | Andrew D. Greenhalgh (Author), David Brough (Author), Emily M. Robinson (Author), Sylvie Girard (Author), Nancy J. Rothwell (Author), Stuart M. Allan (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2012-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microglial heterogeneity after subarachnoid haemorrhage
by: Ian Galea
Published: (2022) -
Clinical Practice Guidelines for Subarachnoid Haemorrhage Treatment
by: José Ramón Tejera del Valle, et al.
Published: (2009) -
Clinical Practice Guidelines for Subarachnoid Haemorrhage Treatment
by: José Ramón Tejera del Valle, et al.
Published: (2009) -
Postpartum Seizure and Subarachnoid Haemorrhage Secondary to Moyamoya Disease
by: L. Chitra Varanasi, et al.
Published: (2019) -
Prognostic value of serum copeptin level in patients with subarachnoid haemorrhage
by: N. M. Buchakchyiska, et al.
Published: (2018)